CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban

• 主要な著者: Sychev DA (著者), Baturina OA (著者), Mirzaev KB (著者), Rytkin E (著者), Ivashchenko DV (著者), Andreev DA (著者), Ryzhikova KA (著者), Grishina EA (著者), Bochkov PO (著者), Shevchenko RV (著者)
• フォーマット: 図書
• 出版事項: Dove Medical Press, 2020-01-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

DA Sychev,1 OA Baturina,2 KB Mirzaev,1 E Rytkin,1 DV Ivashchenko,1 DA Andreev,2 KA Ryzhikova,1 EA Grishina,1 PO Bochkov,1 RV Shevchenko1 1Russian Medical Academy of Continuous Professional Education, Ministry of Health of the Russian Federation, Moscow, Russian Federation; 2Sechenov University, Mosc...